trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

First-line medications for hypertension include thiazide-diuretics, calcium channel blockers, angiotensin converting enzyme inhibitors (ACE inhibitors), and angiotensin receptor blockers (ARBs).

the verdict
SUPPORTED
the evidence backs this
Recorded sources
2 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that first-line medications for hypertension include thiazide-diuretics, calcium channel blockers, angiotensin converting enzyme inhibitors (ACE inhibitors), and angiotensin receptor blockers (ARBs)?

Yes. Standard clinical guidelines consistently identify thiazide diuretics, calcium channel blockers, ACE inhibitors, and angiotensin receptor blockers as the core first-line pharmacological treatments for hypertension.

Verdict: SUPPORTED · 2 sources for, 0 against · Last checked

The analysis

The claim states that thiazide-diuretics, calcium channel blockers, ACE inhibitors, and ARBs are first-line medications for hypertension. Multiple retrieved clinical papers (such as [5] and [8]) explicitly list these four major drug classes as standard first-line or guideline-recommended choices. There is no evidence refuting this standard medical consensus.

Evidence for · 2
Comparative effectiveness of GLP-1 receptor agonists versus mineralocorticoid receptor antagonists as fourth-line pharmacological therapy in patients with resistant hypertension and overweight or obesity: a retrospective multicenter cohort study in the USA.
2026
Get citation
Z, T., JM, W., KM, S., A, M., & BMW, S. (2026). Comparative effectiveness of GLP-1 receptor agonists versus mineralocorticoid receptor antagonists as fourth-line pharmacological therapy in patients with resistant hypertension and overweight or obesity: a retrospective multicenter cohort study in the USA.. doi.org. https://doi.org/10.1016/j.eclinm.2026.104176

See more details
More for · 1
Benefits Beyond Hypertension Control: Current and Evolving Treatment Strategies for Prevention of Cardiovascular Diseases.
2026
Get citation
A, T., A, A., S, D., S, B., JP, B., A, B., AH, Z., S, C., S, K., N, D., D, J., & S, J. (2026). Benefits Beyond Hypertension Control: Current and Evolving Treatment Strategies for Prevention of Cardiovascular Diseases.. doi.org. https://doi.org/10.2174/0115734021435628260415113327

What does the evidence say?

The claim states that thiazide-diuretics, calcium channel blockers, ACE inhibitors, and ARBs are first-line medications for hypertension. Multiple retrieved clinical papers (such as [5] and [8]) explicitly list these four major drug classes as standard first-line or guideline-recommended choices. There is no evidence refuting this standard medical consensus.

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work